OvaScience (OVAS) PT Trimmed at Wedbush

Wedbush analyst Zarak Khurshid trimmed his price target on OvaScience (NASDAQ: OVAS) to $52.00 (from $57.00) following Q1 revenues that was a little below the firm's and the Street consensus, but maintained an Outperform rating.

Khurshid commented, "Difficult to draw meaningful volume conclusions from the 1Q15 results given the early phase of launch and lack of color from the company. We are reserving stronger judgement until Fakih IVF (Dubai) potentially discusses AUGMENT volume at the ESHRE conference June 14-17, 2015."

The firm is lowering estimates slightly due to slower revenue recognition.

For an analyst ratings summary and ratings history on OvaScience click here. For more ratings news on OvaScience click here.

Shares of OvaScience closed at $27.91 yesterday.

You May Also Be Interested In

• IG Group Holdings (IGG:LN) (IGGHY) PT Raised to GBP20 at Deutsche Bank
• Stifel Downgrades Adobe (ADBE) to Hold
• Piper Sandler Assumes Medallion Financial (MFIN) at Neutral